First-ever gene therapy for hearing loss gets FDA approval: 'Groundbreaking'
Summary
The FDA has approved Otarmeni, the first-ever dual AAV vector-based gene therapy for genetic hearing loss, marking a groundbreaking milestone for patients with ...
Description
The FDA has approved Otarmeni, the first-ever dual AAV vector-based gene therapy for genetic hearing loss, marking a groundbreaking milestone for patients with ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source